IBEX
BULLISH
$27.49
Live
IBEX Limited · NASDAQ
Target $37.5
(+36.4%)
$22.63
52W Range
$42.99
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Apr 12, 2026
Market cap
$370.21M
P/E
9.13
ROE
33.6%
Profit margin
7.3%
Debt/Equity
0.42
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
85%
IBEX exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial stability and operational efficiency. The stock is currently trading at $27.49, which is essentially at its Graham Number ($27.9) and significantly below its growth-based intrinsic value of $88.79. Despite a bearish technical trend and recent insider selling by the CEO, the combination of a low P/E (9.13), high ROE (33.65%), and robust earnings growth (45.6% YoY) presents a compelling value opportunity.
Key Strengths
Strong financial health evidenced by a Piotroski F-Score of 8/9
Highly attractive valuation with a P/E of 9.13 and P/S of 0.61
Exceptional profitability with an ROE of 33.65% and ROA of 12.44%
Consistent earnings outperformance with 3 of the last 4 quarters beating estimates
Strong growth profile with 45.6% YoY earnings growth and 16.7% revenue growth
Key Risks
Bearish technical momentum with a 23.4% decline over the last 6 months
Negative insider sentiment characterized by CEO share liquidations
Low analyst coverage (only 2 analysts) limiting market visibility
Lack of dividend yield for income-seeking investors
Potential sector volatility within Information Technology Services
AI Fair Value Estimate
Based on comprehensive analysis
$48.5
+76.4% above current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
69
Strong
95
88
70
92
0
AI Verdict
Strong Value Play
Key drivers: Piotroski F-Score, P/E vs Growth, ROE, Graham Number alignment
Confidence
90%
Value
95/100
P/E of 9.13 is extremely low for a company growing earnings at 45%.
Positives
- Trading at Graham Number
- P/E significantly lower than sector average
- Low Price/Sales ratio
Watchpoints
- Price/Book is slightly elevated at 2.39
Future
88/100
Growth rates are robust and sustainable based on historical beats.
Positives
- Strong YoY earnings growth
- Consistent quarterly beats
- Positive revenue trajectory
Watchpoints
- Recent Q/Q EPS growth dip of -3.3%
Past
70/100
Strong operational history offset by recent poor price action.
Positives
- Long-term 5Y price appreciation of 17.7%
- Consistent earnings progression over 24 quarters
Watchpoints
- Severe 6-month price correction (-23.4%)
Health
92/100
High F-Score indicates very low risk of financial distress.
Positives
- Piotroski F-Score 8/9
- Healthy Current Ratio (1.83)
- Manageable Debt/Equity (0.42)
Watchpoints
- Altman Z-Score data unavailable
Dividend
0/100
Company reinvests all capital into growth.
Positives
No standout positives identified.
Watchpoints
- No dividend payments
- 0% payout ratio
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$27.49
Analyst Target
$37.5
Upside/Downside
+36.4%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for IBEX and closest competitors.
Updated 2026-04-10
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
IBEX
IBEX Limited
Primary
|
+17.7% | +15.1% | +18.9% | -23.4% | -6.2% | -0.8% |
|
CLFD
Clearfield, Inc.
Peer
|
-15.7% | -44.9% | +1.4% | -26.4% | -12.7% | -1.8% |
|
CLMB
Climb Global Solutions, Inc.
Peer
|
+258.4% | +62.8% | -14.2% | -38.6% | -0.6% | +5.5% |
|
BGIN
Bgin Blockchain Limited
Peer
|
-29.5% | -29.5% | -29.5% | -29.5% | +31.4% | -1.0% |
|
API
Agora, Inc.
Peer
|
-94.3% | +22.4% | -27.2% | +1.3% | -10.3% | -11.8% |
IBE
IBEX Limited
Primary
5Y
+17.7%
3Y
+15.1%
1Y
+18.9%
6M
-23.4%
1M
-6.2%
1W
-0.8%
CLF
Clearfield, Inc.
Peer
5Y
-15.7%
3Y
-44.9%
1Y
+1.4%
6M
-26.4%
1M
-12.7%
1W
-1.8%
CLM
Climb Global Solutions, Inc.
Peer
5Y
+258.4%
3Y
+62.8%
1Y
-14.2%
6M
-38.6%
1M
-0.6%
1W
+5.5%
BGI
Bgin Blockchain Limited
Peer
5Y
-29.5%
3Y
-29.5%
1Y
-29.5%
6M
-29.5%
1M
+31.4%
1W
-1.0%
API
Agora, Inc.
Peer
5Y
-94.3%
3Y
+22.4%
1Y
-27.2%
6M
+1.3%
1M
-10.3%
1W
-11.8%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
9.13
Forward P/E
7.51
PEG Ratio
N/A
P/B Ratio
2.39
P/S Ratio
0.61
EV/Revenue
0.69
EV/EBITDA
5.62
Market Cap
$370.21M
Profitability
Profit margins and return metrics
Profit Margin
7.35%
Operating Margin
9.31%
Gross Margin
30.36%
ROE
33.65%
ROA
12.44%
Growth
Revenue and earnings growth rates
Revenue Growth
+16.7%
Earnings Growth
+45.6%
Q/Q Revenue Growth
+16.73%
Q/Q Earnings Growth
+31.8%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.42
Low debt
Current Ratio
1.83
Good
Quick Ratio
1.69
Excellent
Cash/Share
$1.15
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$0.2B
Gross Margin
29.0%
Op. Margin
9.3%
Net Margin
7.4%
Total Assets
$0.3B
Liabilities
$0.1B
Equity
$0.2B
Debt/Equity
0.91x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
-77%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-05-07
$N/A
2026-02-05
$0.87
+10.8% surprise
2025-11-06
$0.9
+22.4% surprise
2025-09-11
$0.87
+24.3% surprise
Technology Sector Comparison
Comparing IBEX against 262 companies in the Technology sector
(24 bullish, 90 neutral, 148 bearish)
P/E Ratio
9.13
This Stock
vs
65.35
Sector Avg
-86.0%
(Discount)
Return on Equity (ROE)
33.65%
This Stock
vs
-25.88%
Sector Avg
-230.0%
(Below Avg)
Profit Margin
7.35%
This Stock
vs
-10.67%
Sector Avg
-168.9%
(Weaker)
Debt to Equity
0.42
This Stock
vs
0.73
Sector Avg
-43.3%
(Less Debt)
Revenue Growth
16.7%
This Stock
vs
9374.82%
Sector Avg
-99.8%
(Slower)
Current Ratio
1.83
This Stock
vs
3.77
Sector Avg
-51.4%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
IBEX
IBEX Limited
|
BULLISH | $370.21M | 9.13 | 33.6% | 7.3% | $27.49 | |
|
CLFD
Clearfield, Inc.
|
NEUTRAL | $360.01M | 57.78 | 2.5% | -4.4% | $26.0 | Compare |
|
CLMB
Climb Global Solutions, Inc.
|
NEUTRAL | $385.04M | 18.02 | 20.6% | 3.3% | $20.9 | Compare |
|
BGIN
Bgin Blockchain Limited
|
BEARISH | $395.52M | - | -32.7% | -28.2% | $3.5 | Compare |
|
API
Agora, Inc.
|
NEUTRAL | $344.03M | 9.57 | 1.7% | 6.8% | $3.83 | Compare |
IBEX
IBEX Limited
BULLISH
Mkt Cap
$370M
P/E
9.1
ROE
33.6%
Price
$27.49
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-02 | JONES JOHN WILLIAM | Director | Stock Award | 2,250 | - |
| 2026-03-02 | BECK FIONA ELIZABETH | Director | Stock Award | 2,083 | - |
| 2026-03-02 | KEEN SHUJA | Director | Stock Award | 5,000 | - |
| 2026-03-02 | BALLOU-AARES DANIELLA | Director | Stock Award | 2,083 | - |
| 2026-03-02 | MCGINNIS PATRICK J. | Director | Stock Award | 2,083 | - |
| 2026-03-02 | ZHUANG MINGZHE | Director | Stock Award | 2,083 | - |
| 2026-03-02 | BATUNGBACAL KAREN | Director | Stock Award | 2,083 | - |
| 2026-02-26 | DECHANT ROBERT THOMAS | Chief Executive Officer | Stock Award | 18,000 | - |
| 2026-02-26 | GREENWALD TAYLOR C | Chief Financial Officer | Stock Award | 5,500 | - |
| 2026-02-26 | INSON PAUL JOSEPH | Officer | Stock Award | 4,000 | - |
| 2026-02-26 | AFDAHL DAVID MARTIN | Chief Operating Officer | Stock Award | 4,400 | - |
| 2026-02-26 | CASTEEL JULIE K | Officer | Stock Award | 4,400 | - |
| 2026-02-26 | DAWSON BRUCE NEIL | Officer | Stock Award | 3,250 | - |
| 2026-02-26 | TROFIMUK-O'CONNOR CHRISTINA ALICE | Officer | Stock Award | 4,400 | - |
| 2026-02-23 | DECHANT ROBERT THOMAS | Chief Executive Officer | Sale | 6,000 | $170,753 |
JONES JOHN WILLIAM
Director
2026-03-02
2,250 shares
BECK FIONA ELIZABETH
Director
2026-03-02
2,083 shares
KEEN SHUJA
Director
2026-03-02
5,000 shares
BALLOU-AARES DANIELLA
Director
2026-03-02
2,083 shares
MCGINNIS PATRICK J.
Director
2026-03-02
2,083 shares
ZHUANG MINGZHE
Director
2026-03-02
2,083 shares
BATUNGBACAL KAREN
Director
2026-03-02
2,083 shares
DECHANT ROBERT THOMAS
Chief Executive Officer
2026-02-26
18,000 shares
GREENWALD TAYLOR C
Chief Financial Officer
2026-02-26
5,500 shares
INSON PAUL JOSEPH
Officer
2026-02-26
4,000 shares
AFDAHL DAVID MARTIN
Chief Operating Officer
2026-02-26
4,400 shares
CASTEEL JULIE K
Officer
2026-02-26
4,400 shares
DAWSON BRUCE NEIL
Officer
2026-02-26
3,250 shares
TROFIMUK-O'CONNOR CHRISTINA ALICE
Officer
2026-02-26
4,400 shares
DECHANT ROBERT THOMAS
Chief Executive Officer
2026-02-23
6,000 shares
·
$170,753
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
HOLD
2 analysts
RBC Capital
2025-11-10
Sector Perform
Sector Perform
Past News Coverage
Recent headlines mentioning IBEX from our newsroom.
Newest → oldest
No matching news yet.